Jump to main content
Jump to site search

Issue 31, 2018
Previous Article Next Article

In vivo drug tracking with 19F MRI at therapeutic dose

Author affiliations

Abstract

Tracking drugs with 19F MRI would be beneficial for developing theranostics and optimizing drug therapy. To this end, a fluorinated dendritic amphiphile with high 19F MRI sensitivity and biocompatibility has been developed for 19F MRI tracking of doxorubicin (DOX)-loaded liposomes in mice, which may provide an effective platform to in vivo trace various drugs with 19F MRI.

Graphical abstract: In vivo drug tracking with 19F MRI at therapeutic dose

Back to tab navigation

Supplementary files

Publication details

The article was received on 27 Dec 2017, accepted on 21 Mar 2018 and first published on 21 Mar 2018


Article type: Communication
DOI: 10.1039/C7CC09898G
Citation: Chem. Commun., 2018,54, 3875-3878
  •   Request permissions

    In vivo drug tracking with 19F MRI at therapeutic dose

    S. Bo, Y. Yuan, Y. Chen, Z. Yang, S. Chen, X. Zhou and Z. Jiang, Chem. Commun., 2018, 54, 3875
    DOI: 10.1039/C7CC09898G

Search articles by author

Spotlight

Advertisements